Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Stenting Strategies in Left Main Bifurcation
Author(s): Suryono Suryono , Muhammad Farhan Hibatulloh , Alfiyah Ramadhani , et al Added: 1 day ago

Intervention

Vascular Disease and Surgery
Stent Underexpansion and Aorto-ostial Lesions Management
Author(s): Luca Paolucci , Asad Shabbir , Marco Lombardi , et al Added: 1 year ago

Imaging & Diagnostics

Intervention
Consequences and Management of Excessive Ostial Stent Protrusion
Author(s): Arditya Damarkusuma , Paula Mota , Billal Patel , et al Added: 1 year ago

Imaging & Diagnostics

Intervention
Consequences and Management of Excessive Ostial Stent Protrusion
Author(s): Arditya Damarkusuma Added: 1 year ago
In this video, Dr Arditya Damarkusuma (Universitas Gadjah Mada, ID) presents his case report on aorto-ostial lesions, recently published in ICR Journal.This case covers the restenosis of a markedly protruding stent at the right coronary ostium in a 54-year old man, and is unusual in its 10-year longevity. Intravascular ultrasound-guided in-stent restenosis intervention using a wire bumper… View more

Imaging & Diagnostics

Intervention
CREST-2: Stenting Benefits Asymptomatic Carotid Stenosis
Added: 1 week ago Source:  Radcliffe Vascular
The optimal management for asymptomatic carotid stenosis has been a subject of debate, particularly with advancements in medical therapy. New findings from the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) provide clarity, suggesting a benefit for carotid-artery stenting when added to intensive medical management.¹MethodologyCREST-2 involved… View more

Intervention

Prevention & Chronic Conditions
IVUS123 workflow for PCI
Author(s): Simon J Walsh , Rafael Cavalcante , Kevin Croce , et al Added: 3 weeks ago

Guidelines & Statements

Intervention
CREST-2: Stenting Benefits in Asymptomatic Carotid Stenosis
Added: 3 weeks ago Source:  Radcliffe Vascular
The optimal management for patients with high-grade asymptomatic carotid stenosis remains a key clinical question, particularly with advancements in medical therapy and revascularisation techniques. The CREST-2 trials were designed to assess whether adding revascularisation to intensive medical management provides a greater benefit than intensive medical management alone in this patient… View more

Guidelines & Statements

Intervention
Added: 7 months ago Source:  Radcliffe Cardiology
AUTHOR: Greg GuilloryThe selection of drug-eluting stents (DES) for percutaneous coronary intervention (PCI) involves balancing efficacy against safety. The SORT OUT XI randomised trial aimed to compare a newer-generation biolimus-eluting stent with a contemporary dual-therapy sirolimus-eluting stent in a real-world patient population, providing crucial head-to-head evidence.¹SORT OUT XI was a… View more

Intervention

MI/ACS
TCT 2025: SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
Author(s): Christian Spaulding Added: 3 months ago
TCT 2025 — Prof Christian M Spaulding (European Hospital Georges Pompidou & INSERM U 970, FR), principal investigator of the SELUTION DeNovo trial (M.A. Med Alliance S.A.; NCT04859985), joins us to share the one year results.This international, multicentre randomised trial enrolled over 3,300 patients at 50 sites across Europe and Asia to compare a sirolimus-eluting balloon (SEB) plus provisional… View more

Intervention
CIRSE 25: The BIONETIC-I Study
Author(s): Marianne Brodmann Added: 4 months ago
CIRSE Congress 2025 - 24-month results show the Biotronik Dynetic-35 cobalt chromium balloon-expandable stent was safe and effective in iliac arteries.Prof Marianne Brodmann (Medical University of Graz, Graz, AT) joins us to discuss 24-month findings from BIONETIC-I (NCT04830228). The prospective, international, multi-center, single-arm study aimed to investigate the safety and effectiveness of… View more

Intervention

Vascular Disease and Surgery